This becomes important when considering the effects of the downregulation of RhoBTB1 and 2 in cancer cells, where loss of one isoform could potentially increase homodimer concentration of the other, in addition to the simpler effects of reducing its own concentration. The gene discussed is RHOBTB1; the disease is cancer.